Mantle Cell Lymphoma
News
New BTK inhibitor under review in China
Zanubrutinib is being reviewed for treatment of relapsed/refractory mantle cell lymphoma.
News
Meta-analysis supports rituximab maintenance in MCL
Rituximab maintenance therapy prolonged progression-free survival. Risk of grade 3 or 4 neutropenia was increased, but risk of infection was not...
News
PET/CT accurately predicts MCL stage
The promising results suggest bone marrow involvement could be assessed without a biopsy.
News
Late mortality risk after childhood BMT is substantial, persistent
Patients who undergo blood or marrow transplant as children need “lifelong follow-up care.”
News
New guideline for managing MCL
News
Bortezomib plus vorinostat shows modest response in MCL
The phase 2 trial looked at the combination in mantle cell lymphoma and diffuse large B-cell lymphoma patients.
News
British good practice paper offers MCL diagnosis pearls
The good practice paper includes new information on pathology and use of PET/CT scanning in staging of disease.
News
Overcoming TP53 mutation proves difficult in MCL
A new study shows disappointing results for the addition of lenalidomide to chemoimmunotherapy regimens.
News
Adding bortezomib does not improve MCL outcomes
The addition of bortezomib is a bust in patients with newly diagnosed mantle cell lymphoma.
News
In young MCL patients, optimal treatment may vary
Novel agents have produced mixed results in younger mantle cell lymphoma patients.